Page last updated: 2024-08-21

alpha-aminopyridine and Myeloproliferative Disorders

alpha-aminopyridine has been researched along with Myeloproliferative Disorders in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Fu, JF; Guo, C; Li, B; Liang, AB; Wu, H; Zhou, J; Zhou, LL1
Artz, AS; Cahill, K; Charnot-Katsikas, A; Gurbuxani, S; Kosuri, S; Larson, RA; Liu, H; Odenike, O; Patel, AA; Segal, J; Stock, W; Thirman, M1
Hubbard, SR; Silvennoinen, O1

Other Studies

3 other study(ies) available for alpha-aminopyridine and Myeloproliferative Disorders

ArticleYear
Dnmt3a is downregulated by Stat5a and mediates G0/G1 arrest by suppressing the miR-17-5p/Cdkn1a axis in Jak2
    BMC cancer, 2021, Nov-13, Volume: 21, Issue:1

    Topics: Aminopyridines; Animals; Binding Sites; Blotting, Western; Case-Control Studies; Cell Count; Cell Line; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; DNA Methyltransferase 3A; Down-Regulation; Exons; G1 Phase Cell Cycle Checkpoints; Humans; Imidazoles; Janus Kinase 2; K562 Cells; Mice; MicroRNAs; Monocytes; Mutation; Myeloproliferative Disorders; Promoter Regions, Genetic; Pyrazoles; Pyridazines; Signal Transduction; STAT5 Transcription Factor; Transcription, Genetic; Tumor Stem Cell Assay; Tumor Suppressor Proteins; U937 Cells

2021
Clinical outcomes of IDH2-mutated advanced-phase Ph-negative myeloproliferative neoplasms treated with enasidenib.
    British journal of haematology, 2020, Volume: 190, Issue:1

    Topics: Aged; Aged, 80 and over; Aminopyridines; Female; Humans; Isocitrate Dehydrogenase; Male; Middle Aged; Mutation; Myeloproliferative Disorders; Treatment Outcome; Triazines

2020
Targeting the Inactive Conformation of JAK2 in Hematological Malignancies.
    Cancer cell, 2015, Jul-13, Volume: 28, Issue:1

    Topics: Aminopyridines; Animals; Antineoplastic Agents; Benzimidazoles; Dexamethasone; Drug Resistance, Neoplasm; Humans; Janus Kinase 2; Myeloproliferative Disorders; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors

2015